Hijacking PrPc-dependent signal transduction: When prions impair Aβ clearance

Frontiers in Aging Neuroscience

Volumn 6, Issue FEB, 2014, Pages

  Hernandez Rapp, Julia ^a,b,c   Martin Lannerée, Séverine ^a,b   Hirsch, Théo Z ^a,b   Launay, Jean Marie ^d,e   Mouillet Richard, Sophie ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Alzheimer's disease; A clearance; Cellular prion protein; Prion infection; Signal transduction

Indexed keywords

AMYLOID BETA PROTEIN; CELL PROTEIN; PRION PROTEIN;

AMYLOID BETA PROTEIN CLEARANCE; HUMAN; NEUROTOXICITY; NONHUMAN; PRION; PROTEIN AVAILABILITY; PROTEIN MODIFICATION; PROTEIN PRODUCTION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 84895831998     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00025     Document Type: Short Survey

References (79)

1. Aguzzi, A., and Calella, A. M. (2009). Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105-1152. doi: 10.1152/physrev.00006.2009
2. Altmeppen, H. C., Prox, J., Puig, B., Kluth, M. A., Bernreuther, C., Thurm, D., et al. (2011). Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol. Neurodegener. 6, 36. doi: 10.1186/1750-1326-6-36
3. Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., et al. (2010). Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U.S.A. 107, 2295-2300. doi: 10.1073/pnas.0911829107
4. Barry, A. E., Klyubin, I., Mc Donald, J. M., Mably, A. J., Farrell, M. A., Scott, M., et al. (2011). Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci. 31, 7259-7263. doi: 10.1523/JNEUROSCI.6500-10.2011
5. Bate, C., and Williams, A. (2011). Amyloid-beta-induced synapse damage is mediated via cross-linkage of cellular prion proteins. J. Biol. Chem. 286, 37955-37963. doi: 10.1074/jbc. M111.248724
6. Beland, M., Motard, J., Barbarin, A., and Roucou, X. (2012). PrP(C) homodimerization stimulates the production of PrPC cleaved fragments PrPN1 and PrPC1. J. Neurosci. 32, 13255-13263. doi: 10.1523/JNEUROSCI.2236-12.2012
7. Benilova, I., and De Strooper, B. (2013). Neuroscience. Promiscuous Alzheimer's amyloid: yet another partner. Science 341, 1354-1355. doi: 10.1126/science.1244166
8. Benilova, I., Karran, E., and De Strooper, B. (2012). The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 15, 349-357. doi: 10.1038/nn.3028
9. Beraldo, F. H., Arantes, C. P., Santos, T. G., Machado, C. F., Roffe, M., Hajj, G. N., et al. (2011). Metabotropic glutamate receptors transduce signals for neurite outgrowth after binding of the prion protein to laminin gamma1 chain. FASEB J. 25, 265-279. doi: 10.1096/fj.10-161653
10. Beraldo, F. H., Arantes, C. P., Santos, T. G., Queiroz, N. G., Young, K., Rylett, R. J., et al. (2010). Role of alpha7 nicotinic acetylcholine receptor in calcium signaling induced by prion protein interaction with stress-inducible protein 1. J. Biol. Chem. 285, 36542-36550. doi: 10.1074/jbc. M110.157263
11. Bueler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Autenried, P., Aguet, M., et al. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347. doi: 10.1016/0092-8674(93)90360-3
12. Caetano, F. A., Beraldo, F. H., Hajj, G. N., Guimaraes, A. L., Jurgensen, S., Wasilewska-Sampaio, A. P., et al. (2011). Amyloid-beta oligomers increase the localization of prion protein at the cell surface. J. Neurochem. 117, 538-553. doi: 10.1111/j.1471-4159.2011.07225.x
13. Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., et al. (2010). Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314. doi: 10.1002/emmm.201000082
14. Checler, F., and Vincent, B. (2002). Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci. 25, 616-620. doi: 10.1016/S0166-2236(02)02263-4
15. Chen, S., Yadav, S. P., and Surewicz, W. K. (2010). Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role of N-terminal residues. J. Biol. Chem. 285, 26377-26383. doi: 10.1074/jbc. M110.145516
16. Chesebro, B., Trifilo, M., Race, R., Meade-White, K., Teng, C., Lacasse, R., et al. (2005). Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439. doi: 10.1126/science.1110837
17. Chiarini, L. B., Freitas, A. R., Zanata, S. M., Brentani, R. R., Martins, V. R., and Linden, R. (2002). Cellular prion protein transduces neuroprotective signals. EMBO J. 21, 3317-3326. doi: 10.1093/emboj/cdf324
18. Cisse, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., et al. (2011). Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469, 47-52. doi: 10.1038/nature09635
19. Coitinho, A. S., Freitas, A. R., Lopes, M. H., Hajj, G. N., Roesler, R., Walz, R., et al. (2006). The interaction between prion protein and laminin modulates memory consolidation. Eur. J. Neurosci. 24, 3255-3264. doi: 10.1111/j.1460-9568.2006.05156.x
20. Coitinho, A. S., Lopes, M. H., Hajj, G. N., Rossato, J. I., Freitas, A. R., Castro, C. C., et al. (2007). Short-term memory formation and long-term memory consolidation are enhanced by cellular prion association to stress-inducible protein 1. Neurobiol. Dis. 26, 282-290. doi: 10.1016/j.nbd.2007.01.005
21. Debatin, L., Streffer, J., Geissen, M., Matschke, J., Aguzzi, A., and Glatzel, M. (2008). Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease. Neurodegener. Dis. 5, 347-354. doi: 10.1159/000121389
22. De Strooper, B. (2010). Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol. Rev. 90, 465-494. doi: 10.1152/physrev.00023.2009
23. Ermonval, M., Mouillet-Richard, S., Codogno, P., Kellermann, O., and Botti, J. (2003). Evolving views in prion glycosylation: functional and pathological implications. Biochimie 85, 33-45. doi: 10.1016/S0300-9084(03)00040-3
24. Falsig, J., Sonati, T., Herrmann, U. S., Saban, D., Li, B., Arroyo, K., et al. (2012). Prion pathogenesis is faithfully reproduced in cerebellar organotypic slice cultures. PLoS Pathog. 8:e1002985. doi: 10.1371/journal.ppat.1002985
25. Fragkouli, A., Papatheodoropoulos, C., Georgopoulos, S., Stamatakis, A., Stylianopoulou, F., Tsilibary, E. C., et al. (2012). Enhanced neuronal plasticity and elevated endogenous sAPPalpha levels in mice over-expressing MMP9. J. Neurochem. 121, 239-251. doi: 10.1111/j.1471-4159.2011.07637.x
26. Freir, D. B., Nicoll, A. J., Klyubin, I., Panico, S., Mc Donald, J. M., Risse, E., et al. (2011). Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336. doi: 10.1038/ncomms1341
27. Griffiths, H. H., Whitehouse, I. J., Baybutt, H., Brown, D., Kellett, K. A., Jackson, C. D., et al. (2011). Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein. J. Biol. Chem. 286, 33489-33500. doi: 10.1074/jbc. M111.278556
28. Guillot-Sestier, M. V., and Checler, F. (2012). α-Secretase-derived cleavage of cellular prion yields biologically active catabolites with distinct functions. Neurodegener. Dis. 10, 294-297. doi: 10.1159/000333804
29. Guillot-Sestier, M. V., Sunyach, C., Ferreira, S. T., Marzolo, M. P., Bauer, C., Thevenet, A., et al. (2012). α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid beta (Abeta)-associated cell death. J. Biol. Chem. 287, 5021-5032. doi: 10.1074/jbc. M111.323626
30. Haass, C., and Selkoe, D. J. (2007). Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112. doi: 10.1038/nrm2101
31. Hainfellner, J. A., Wanschitz, J., Jellinger, K., Liberski, P. P., Gullotta, F., and Budka, H. (1998). Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol. 96, 116-122. doi: 10.1007/s004010050870
32. Harris, D. A., and True, H. L. (2006). New insights into prion structure and toxicity. Neuron 50, 353-357. doi: 10.1016/j.neuron.2006.04.020
33. Ittner, L. M., and Gotz, J. (2011). Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65-72. doi: 10.1038/nrn2967
34. Jucker, M., and Walker, L. C. (2013). Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501, 45-51. doi: 10.1038/nature12481
35. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010). The prion protein as a receptor for amyloid-beta. Nature 466, E3-E4; discussion E4-E5. doi: 10.1038/nature09217
36. Kovacs, G. G., and Budka, H. (2008). Prion diseases: from protein to cell pathology. Am. J. Pathol. 172, 555-565. doi: 10.2353/ajpath.2008.070442
37. Krebs, B., Wiebelitz, A., Balitzki-Korte, B., Vassallo, N., Paluch, S., Mitteregger, G., et al. (2007). Cellular prion protein modulates the intracellular calcium response to hydrogen peroxide. J. Neurochem. 100, 358-367. doi: 10.1111/j.1471-4159.2006.04256.x
38. Kudo, W., Lee, H. P., Zou, W. Q., Wang, X., Perry, G., Zhu, X., et al. (2012). Cellular prion protein is essential for oligomeric amyloid-beta-induced neuronal cell death. Hum. Mol. Genet. 21, 1138-1144. doi: 10.1093/hmg/ddr542
39. Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., and Jucker, M. (2011). Soluble Abeta seeds are potent inducers of cerebral beta-amyloid deposition. J. Neurosci. 31, 14488-14495. doi: 10.1523/JNEUROSCI.3088-11.2011
40. Larson, M., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., et al. (2012). The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease. J. Neurosci. 32, 16857-16871a. doi: 10.1523/JNEUROSCI.1858-12.2012
41. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009). Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132. doi: 10.1038/nature07761
42. Lewis, V., and Hooper, N. M. (2011). The role of lipid rafts in prion protein biology. Front. Biosci. 16:151-168. doi: 10.2741/3681
43. Linden, R., Martins, V. R., Prado, M. A., Cammarota, M., Izquierdo, I., and Brentani, R. R. (2008). Physiology of the prion protein. Physiol. Rev. 88, 673-728. doi: 10.1152/physrev.00007.2007
44. Lopes, M. H., Hajj, G. N., Muras, A. G., Mancini, G. L., Castro, R. M., Ribeiro, K. C., et al. (2005). Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J. Neurosci. 25, 11330-11339. doi: 10.1523/JNEUROSCI.2313-05.2005
45. Ma, T., Trinh, M. A., Wexler, A. J., Bourbon, C., Gatti, E., Pierre, P., et al. (2013). Suppression of eIF2alpha kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat. Neurosci. 16, 1299-1305. doi: 10.1038/nn.3486
46. Mallucci, G., Dickinson, A., Linehan, J., Klohn, P. C., Brandner, S., and Collinge, J. (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874. doi: 10.1126/science.1090187
47. McMahon, H. E. (2012). Prion processing: a double-edged sword? Biochem. Soc. Trans. 40, 735-738. doi: 10.1042/BST20120031
48. Morales, R., Estrada, L. D., Diaz-Espinoza, R., Morales-Scheihing, D., Jara, M. C., Castilla, J., et al. (2010). Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases. J. Neurosci. 30, 4528-4535. doi: 10.1523/JNEUROSCI.5924-09.2010
49. Moreno, J. A., Radford, H., Peretti, D., Steinert, J. R., Verity, N., Martin, M. G., et al. (2012). Sustained translational repression by eIF2alpha-P mediates prion neurodegeneration. Nature 485, 507-511. doi: 10.1038/nature11058
50. Mouillet-Richard, S., Ermonval, M., Chebassier, C., Laplanche, J. L., Lehmann, S., Launay, J. M., et al. (2000). Signal transduction through prion protein. Science 289, 1925-1928. doi: 10.1126/science.289.5486.1925
51. Mouillet-Richard, S., Nishida, N., Pradines, E., Laude, H., Schneider, B., Feraudet, C., et al. (2008). Prions impair bioaminergic functions through serotonin-or catecholamine-derived neurotoxins in neuronal cells. J. Biol. Chem. 283, 23782-23790. doi: 10.1074/jbc. M802433200
52. Mouillet-Richard, S., Pietri, M., Schneider, B., Vidal, C., Mutel, V., Launay, J. M., et al. et al. (2005). Modulation of serotonergic receptor signaling and cross-talk by prion protein. J. Biol. Chem. 280, 4592-4601. doi: 10.1074/jbc. M406199200
53. Muramoto, T., Kitamoto, T., Koga, H., and Tateishi, J. (1992). The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration. Acta Neuropathol. 84, 686-689. doi: 10.1007/BF00227747
54. Nicoll, A. J., Panico, S., Freir, D. B., Wright, D., Terry, C., Risse, E., et al. (2013). Amyloid-beta nanotubes are associated with prion protein-dependent synaptotoxicity. Nat. Commun. 4, 2416. doi: 10.1038/ncomms3416
55. Ostapchenko, V. G., Beraldo, F. H., Mohammad, A. H., Xie, Y. F., Hirata, P. H., Magalhaes, A. C., et al. (2013). The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-beta oligomer toxicity. J. Neurosci. 33, 16552-16564. doi: 10.1523/JNEUROSCI.3214-13.2013
56. Parkin, E. T., Watt, N. T., Hussain, I., Eckman, E. A., Eckman, C. B., Manson, J. C., et al. (2007). Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 104, 11062-11067. doi: 10.1073/pnas.0609621104
57. Parton, R. G., and del Pozo, M. A. (2013). Caveolae as plasma membrane sensors, protectors and organizers. Nat. Rev. Mol. Cell Biol. 14, 98-112. doi: 10.1038/nrm3512
58. Pflanzner, T., Petsch, B., Andre-Dohmen, B., Muller-Schiffmann, A., Tschickardt, S., Weggen, S., et al. (2012). Cellular prion protein participates in amyloid-beta transcytosis across the blood-brain barrier. J. Cereb. Blood Flow Metab. 32, 628-632. doi: 10.1038/jcbfm.2012.7
59. Pietri, M., Dakowski, C., Hannaoui, S., Alleaume-Butaux, A., Hernandez-Rapp, J., Ragagnin, A., et al. (2013). PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer's diseases. Nat. Med. 19, 1124-1131. doi: 10.1038/nm.3302
60. Pradines, E., Hernandez-Rapp, J., Villa-Diaz, A., Dakowski, C., Ardila-Osorio, H., Haik, S., et al. (2013). Pathogenic prions deviate PrP(C) signaling in neuronal cells and impair A-beta clearance. Cell Death Dis. 4:e456. doi: 10.1038/cddis.2012.195
61. Pradines, E., Loubet, D., Mouillet-Richard, S., Manivet, P., Launay, J. M., Kellermann, O., et al. (2009). Cellular prion protein coupling to TACE-dependent TNF-alpha shedding controls neurotransmitter catabolism in neuronal cells. J. Neurochem. 110, 912-923. doi: 10.1111/j.1471-4159.2009.06176.x
62. Pradines, E., Loubet, D., Schneider, B., Launay, J. M., Kellermann, O., and Mouillet-Richard, S. (2008). CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan. Cell. Signal. 20, 2050-2058. doi: 10.1016/j.cellsig.2008.07.016
63. Reiniger, L., Lukic, A., Linehan, J., Rudge, P., Collinge, J., Mead, S., et al. (2011). Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol. 121, 5-20. doi: 10.1007/s00401-010-0691-0
64. Resenberger, U. K., Harmeier, A., Woerner, A. C., Goodman, J. L., Muller, V., Krishnan, R., et al. (2011a). The cellular prion protein mediates neurotoxic signalling of beta-sheet-rich conformers independent of prion replication. EMBO J. 30, 2057-2070. doi: 10.1038/emboj.2011.86
65. Resenberger, U. K., Winklhofer, K. F., and Tatzelt, J. (2011b). Neuroprotective and neurotoxic signaling by the prion protein. Top. Curr. Chem. 305, 101-119. doi: 10.1007/128_2011_160
66. Roberson, E. D., Halabisky, B., Yoo, J. W., Yao, J., Chin, J., Yan, F., et al. (2011). Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J. Neurosci. 31, 700-711. doi: 10.1523/JNEUROSCI.4152-10.2011
67. Roffe, M., Beraldo, F. H., Bester, R., Nunziante, M., Bach, C., Mancini, G., et al. (2010). Prion protein interaction with stress-inducible protein 1 enhances neuronal protein synthesis via mTOR. Proc. Natl. Acad. Sci. U.S.A. 107, 13147-13152. doi: 10.1073/pnas.1000784107
68. Rushworth, J. V., Griffiths, H. H., Watt, N. T., and Hooper, N. M. (2013). Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1. J. Biol. Chem. 288, 8935-8951. doi: 10.1074/jbc. M112.400358
69. 2+ mobilization in dorsal root ganglia neurons. J. Neurochem. 124, 210-223. doi: 10.1111/jnc.12091
70. Santuccione, A., Sytnyk, V., Leshchyns'ka, I., and Schachner, M. (2005). Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J. Cell Biol. 169, 341-354. doi: 10.1083/jcb.200409127
71. Schneider, B., Mutel, V., Pietri, M., Ermonval, M., Mouillet-Richard, S., and Kellermann, O. (2003). NADPH oxidase and extracellular regulated kinases 1/2 are targets of prion protein signaling in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. U.S.A. 100, 13326-13331. doi: 10.1073/pnas.2235648100
72. Silveira, J. R., Raymond, G. J., Hughson, A. G., Race, R. E., Sim, V. L., Hayes, S. F., et al. (2005). The most infectious prion protein particles. Nature 437, 257-261. doi: 10.1038/nature03989
73. Steele, A. D., Lindquist, S., and Aguzzi, A. (2007). The prion protein knockout mouse: a phenotype under challenge. Prion 1, 83-93. doi: 10.4161/pri.1.2.4346
74. Stys, P. K., You, H., and Zamponi, G. W. (2012). Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders. J. Physiol. 590, 1357-1368. doi: 10.1113/jphysiol.2011.225276
75. Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., et al. (2013). Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein. Neuron 79, 887-902. doi: 10.1016/j.neuron.2013.06.036
76. Um, J. W., Nygaard, H. B., Heiss, J. K., Kostylev, M. A., Stagi, M., Vortmeyer, A., et al. (2012). Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci. 15, 1227-1235. doi: 10.1038/nn.3178
77. You, H., Tsutsui, S., Hameed, S., Kannanayakal, T. J., Chen, L., Xia, P., et al. (2012). Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 109, 1737-1742. doi: 10.1073/pnas.1110789109
78. Zanata, S. M., Lopes, M. H., Mercadante, A. F., Hajj, G. N., Chiarini, L. B., Nomizo, R., et al. (2002). Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21, 3307-3316. doi: 10.1093/emboj/cdf325
79. Zou, W. Q., Xiao, X., Yuan, J., Puoti, G., Fujioka, H., Wang, X., et al. (2011). Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. J. Biol. Chem. 286, 15095-15105. doi: 10.1074/jbc. M110.199356